Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study

INTRODUCTION: Apremilast is approved for the treatment of psoriasis and psoriatic arthritis (PsA). Real-world evidence on the efficacy and safety of apremilast in clinical practice is limited. We assessed the use of apremilast in patients with PsA in Belgium clinical practice. METHODS: The multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vlam, Kurt, Toukap, Adrien Nzeusseu, Kaiser, Marie-Joëlle, Vanhoof, Johan, Remans, Philip, Van den Berghe, Marthe, Di Romana, Silvana, Van den Bosch, Filip, Lories, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866349/
https://www.ncbi.nlm.nih.gov/pubmed/34977986
http://dx.doi.org/10.1007/s12325-021-02016-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866349/
https://www.ncbi.nlm.nih.gov/pubmed/34977986
http://dx.doi.org/10.1007/s12325-021-02016-x

Ejemplares similares